ProQR Therapeutics N.V. Operating Expense
ProQR Therapeutics N.V. (PRQR) reported Operating Expense of EUR 59.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-12
- ProQR Therapeutics N.V. operating expense for the quarter ending 2025-12-31 was 13.81M EUR, a 4.90% decline year-over-year.
- ProQR Therapeutics N.V. operating expense for the quarter ending 2025-09-30 was 14.20M EUR, a 11.83% increase year-over-year.
- ProQR Therapeutics N.V. operating expense for the quarter ending 2025-06-30 was 16.22M EUR, a 61.26% increase year-over-year.
- ProQR Therapeutics N.V. operating expense for the quarter ending 2025-03-31 was 15.56M EUR, a 22.16% increase year-over-year.
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 9 month | Operating Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | 13.81M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 28.01M EUR derived: sum of 2 quarters · filed 2026-03-12 | 44.24M EUR derived: sum of 3 quarters · filed 2026-03-12 | 59.79M EUR 20-F · filed 2026-03-12 |
| 2025-09-30 | 14.20M EUR 6-K · filed 2025-11-06 | 30.42M EUR derived: sum of 2 quarters · filed 2025-11-06 | 45.98M EUR 6-K · filed 2025-11-06 | 60.50M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | 16.22M EUR 6-K · filed 2025-08-07 | 31.78M EUR 6-K · filed 2025-08-07 | 46.30M EUR derived: sum of 3 quarters · filed 2026-03-12 | 59.00M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | 15.56M EUR 6-K · filed 2025-05-08 | 30.08M EUR derived: sum of 2 quarters · filed 2026-03-12 | 42.78M EUR derived: sum of 3 quarters · filed 2026-03-12 | 52.84M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 14.52M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 27.22M EUR derived: sum of 2 quarters · filed 2026-03-12 | 37.28M EUR derived: sum of 3 quarters · filed 2026-03-12 | 50.02M EUR 20-F · filed 2026-03-12 |
| 2024-09-30 | 12.70M EUR 6-K · filed 2025-11-06 | 22.76M EUR derived: sum of 2 quarters · filed 2025-11-06 | 35.49M EUR 6-K · filed 2025-11-06 | 47.98M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | 10.06M EUR 6-K · filed 2025-08-07 | 22.80M EUR 6-K · filed 2025-08-07 | 35.28M EUR derived: sum of 3 quarters · filed 2026-03-12 | 44.04M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | 12.73M EUR 6-K · filed 2025-05-08 | 25.22M EUR derived: sum of 2 quarters · filed 2026-03-12 | 33.98M EUR derived: sum of 3 quarters · filed 2026-03-12 | 44.03M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | 12.48M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 21.24M EUR derived: sum of 2 quarters · filed 2026-03-12 | 31.30M EUR derived: sum of 3 quarters · filed 2026-03-12 | 41.38M EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | 8.76M EUR 6-K · filed 2024-11-07 | 18.82M EUR derived: sum of 2 quarters · filed 2024-11-07 | 28.90M EUR 6-K · filed 2024-11-07 | 42.57M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | 10.05M EUR 6-K · filed 2024-08-08 | 20.14M EUR 6-K · filed 2024-08-08 | 33.81M EUR derived: sum of 3 quarters · filed 2025-03-13 | 54.52M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | 10.09M EUR 6-K · filed 2024-05-09 | 23.76M EUR derived: sum of 2 quarters · filed 2025-03-13 | 44.47M EUR derived: sum of 3 quarters · filed 2025-03-13 | 61.33M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | 13.67M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | 34.38M EUR derived: sum of 2 quarters · filed 2025-03-13 | 51.24M EUR derived: sum of 3 quarters · filed 2025-03-13 | 69.52M EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | 20.71M EUR 6-K · filed 2023-11-07 | 37.57M EUR derived: sum of 2 quarters · filed 2023-11-07 | 55.85M EUR 6-K · filed 2023-11-07 | 73.62M EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 16.86M EUR 6-K · filed 2023-08-03 | 35.14M EUR 6-K · filed 2023-08-03 | 52.91M EUR derived: sum of 3 quarters · filed 2023-08-03 | 68.62M EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 18.27M EUR 6-K · filed 2023-05-16 | 36.05M EUR derived: sum of 2 quarters · filed 2023-05-16 | 51.76M EUR derived: sum of 3 quarters · filed 2023-05-16 | 65.62M EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | 17.77M EUR 6-K · filed 2022-02-24 | 33.49M EUR derived: sum of 2 quarters · filed 2022-11-09 | 47.34M EUR derived: sum of 3 quarters · filed 2022-11-09 | 59.59M EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | 15.71M EUR 6-K · filed 2022-11-09 | 29.57M EUR derived: sum of 2 quarters · filed 2022-11-09 | 41.82M EUR 6-K · filed 2022-11-09 | 53.75M EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 13.86M EUR 6-K · filed 2022-08-04 | 26.10M EUR 6-K · filed 2022-08-04 | 38.03M EUR derived: sum of 3 quarters · filed 2022-08-04 | 49.15M EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 12.24M EUR 6-K · filed 2022-05-05 | 24.18M EUR derived: sum of 2 quarters · filed 2022-05-05 | 35.29M EUR derived: sum of 3 quarters · filed 2022-05-05 | 47.32M EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 11.93M EUR 6-K · filed 2022-02-24 | 23.04M EUR derived: sum of 2 quarters · filed 2022-02-24 | 35.08M EUR derived: sum of 3 quarters · filed 2022-02-24 | 51.82M EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | 11.11M EUR 6-K · filed 2021-11-04 | 23.15M EUR derived: sum of 2 quarters · filed 2021-11-04 | 39.89M EUR 6-K · filed 2021-11-04 | 57.74M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 12.03M EUR 6-K · filed 2021-08-05 | 28.78M EUR 6-K · filed 2021-08-05 | 46.62M EUR derived: sum of 3 quarters · filed 2021-08-05 | 60.60M EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 16.74M EUR 6-K · filed 2020-05-07 | 34.59M EUR derived: sum of 2 quarters · filed 2021-02-25 | 48.57M EUR derived: sum of 3 quarters · filed 2021-02-25 | 60.97M EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | 17.85M EUR 6-K · filed 2021-02-25 | 31.82M EUR derived: sum of 2 quarters · filed 2021-02-25 | 44.22M EUR derived: sum of 3 quarters · filed 2021-02-25 | 59.38M EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | 13.98M EUR 6-K · filed 2020-11-16 | 26.38M EUR derived: sum of 2 quarters · filed 2020-11-16 | 41.53M EUR 6-K · filed 2020-11-16 | 55.71M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | 12.40M EUR 6-K · filed 2020-08-06 | 27.55M EUR 6-K · filed 2020-08-06 | 41.73M EUR derived: sum of 3 quarters · filed 2021-03-24 | 50.61M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | 15.15M EUR 6-K · filed 2020-05-07 | 29.34M EUR derived: sum of 2 quarters · filed 2021-03-24 | 38.21M EUR derived: sum of 3 quarters · filed 2021-03-24 | 46.85M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | 14.18M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | 23.06M EUR derived: sum of 2 quarters · filed 2021-03-24 | 31.70M EUR derived: sum of 3 quarters · filed 2021-03-24 | 42.05M EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | 8.88M EUR 6-K · filed 2019-11-12 | 17.52M EUR derived: sum of 2 quarters · filed 2019-11-12 | 27.87M EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | 8.64M EUR 6-K · filed 2019-08-07 | 19.00M EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | 41.99M EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | 10.44M EUR 6-K · filed 2018-08-08 | 20.78M EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | 41.40M EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | 30.24M EUR 20-F · filed 2018-03-30 |